Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 757,897 | 516,150 | 861,476 | 219,545 | 81,218 |
| Receivables | 405,214 | 305,725 | 210,437 | 73,915 | 15,958 |
| Inventories | 61,655 | 174,788 | 18,376 | 16,865 | 8,701 |
| TOTAL | $1,268,168 | $1,046,282 | $1,106,147 | $324,695 | $110,765 |
| Non-Current Assets | |||||
| PPE Net | 20,405 | 23,484 | 14,020 | 7,241 | 3,780 |
| Intangibles | 2,874,174 | 3,219,014 | 1,869,921 | 704,833 | 131,094 |
| Other Non-Current Assets | 39,551 | 3,279 | 68,500 | 77,564 | 6,957 |
| TOTAL | $2,934,130 | $3,245,777 | $1,952,441 | $789,638 | $141,831 |
| Total Assets | $4,202,298 | $4,292,059 | $3,058,588 | $1,114,333 | $252,596 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,625 | 7,750 | 4,000 | 48,334 | N/A |
| Accounts payable and accrued liabilities | 34,681 | 52,479 | 16,590 | 21,011 | 9,921 |
| Accrued Expenses | 241,025 | 244,746 | 151,746 | 71,950 | 23,936 |
| TOTAL | $794,969 | $605,852 | $357,552 | $218,671 | $43,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,891,030 | 1,799,743 | 1,132,756 | 297,169 | N/A |
| Deferred Revenues | 6,885 | 3,321 | 1,447 | 1,261 | 1,330 |
| Other Non-Current Liabilities | 347,331 | 318,354 | 132,950 | 50,145 | 245,320 |
| TOTAL | $2,406,019 | $2,422,428 | $1,387,891 | $355,458 | $258,368 |
| Total Liabilities | $3,200,988 | $3,028,280 | $1,745,443 | $574,129 | $301,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 164,570 | 162,335 | 159,884 | 125,100 | 67,733 |
| Common Shares | 16 | 16 | 16 | 13 | 7 |
| Retained earnings | -1,242,117 | -848,021 | -681,187 | -720,719 | -457,116 |
| Other shareholders' equity | -568 | -2,671 | -2,236 | -3,948 | -2,403 |
| TOTAL | $1,001,310 | $1,263,779 | $1,313,145 | $540,204 | $-49,082 |
| Total Liabilities And Equity | $4,202,298 | $4,292,059 | $3,058,588 | $1,114,333 | $252,596 |